WE-C-213AB-03: Preparing for Part II of the ABR Radiotherapy Physics Exam

R Flynn

doi:10.1118/1.4736093

Radiotherapy Physics: in Practice (Second Edition)

Physics in Medicine and Biology ◽

10.1088/0031-9155/46/3/701 ◽

2001 ◽

Vol 46 (3) ◽

pp. 899-899

Author(s):

G Pitchford

Keyword(s):

Radiotherapy Physics

Download Full-text

Early experiences of establishing telemedicine in the radiotherapy physics department at the time of the COVID-19 outbreak: When less staff is more effective

Informatics in Medicine Unlocked ◽

10.1016/j.imu.2020.100480 ◽

2020 ◽

Vol 21 ◽

pp. 100480

Author(s):

Aram Rostami ◽

Mahmoudreza Akbari ◽

Seyed Hadi Molana ◽

Mastaneh Sanei ◽

Farshid Arbabi Kalati ◽

...

Keyword(s):

Early Experiences ◽

Physics Department ◽

Radiotherapy Physics

Download Full-text

A survey of in vivo diode dosimetry in the UK

Journal of Radiotherapy in Practice ◽

10.1017/s1460396999000138 ◽

1999 ◽

Vol 1 (2) ◽

pp. 73-82

Author(s):

Robert Appleyard

Keyword(s):

Quality Assurance ◽

Central Axis ◽

In Vivo Dosimetry ◽

In Vivo Measurements ◽

Radiotherapy Department ◽

Critical Organ ◽

Diode System ◽

The Uk ◽

Radiotherapy Physics

A clear rationale exists for routine in vivo dosimetry as part of an overall quality assurance (QA) programme within a radiotherapy department. A survey was undertaken in order to identify the extent of diode dosimetry practice within the UK.Questionnaires were distributed to 57 radiotherapy physics departments in the UK in order to determine the extent of central axis diode dosimetry and the protocols implemented, the range of other in vivo measurements performed using diodes and the type of equipment used. Fifty-four responses were received. Eighteen departments undertook some form of central axis entrance dosimetry. Fifteen departments could be considered to be doing this routinely. Seven departments indicated planned future use. Six centres routinely undertook exit dosimetry with a further 3 indicating planned future use. Varied protocols for use were reported by those centres undertaking central axis dosimetry. Thirty-two respondents used a diode system for other forms of in vivo measurements with critical organ and TBI dosimetry being the most common. The vast majority used Scanditronix equipment.Despite the distinct benefits of central axis diode dosimetry, this continues to be infrequently adopted as part of a departmental QA programme. However, an indication of a number of departments planning to implement such an approach is reassuring.

Download Full-text